These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32241206)

  • 21. Hyperreflective foci in OCT image as a biomarker of poor prognosis in diabetic macular edema patients treating with Conbercept in China.
    Liu S; Wang D; Chen F; Zhang X
    BMC Ophthalmol; 2019 Jul; 19(1):157. PubMed ID: 31337360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conbercept and Ranibizumab Pretreatments in Vitrectomy with Silicone Oil Infusion for Severe Diabetic Retinopathy.
    Yang KB; Zhang H; Li SJ; Cao JJ; Cheng LN; Lin YX; Tian ZC; Li J; Gu F; Liu ZL
    J Ocul Pharmacol Ther; 2019 Apr; 35(3):161-167. PubMed ID: 30668279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal conbercept improves outcome of proliferative diabetic retinopathy through inhibiting inflammation and oxidative stress.
    Xia JP; Liu SQ; Wang S
    Life Sci; 2021 Jan; 265():118795. PubMed ID: 33227274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of very high- and very low-dose intravitreal aflibercept in patients with neovascular age-related macular degeneration.
    Nguyen QD; Campochiaro PA; Shah SM; Browning DJ; Hudson HL; Sonkin PL; Hariprasad SM; Kaiser PK; Slakter J; Haller JA; Do DV; Mieler W; Chu K; Ingerman A; Vitti R; Berliner AJ; Cedarbaum J;
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):581-8. PubMed ID: 22775078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections.
    Shin YU; Hong EH; Lim HW; Kang MH; Seong M; Cho H
    BMC Ophthalmol; 2017 Oct; 17(1):182. PubMed ID: 28974211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of 1.25 MG versus 2.5 MG intravitreal bevacizumab for diabetic macular edema: six-month results of a randomized controlled trial.
    Lam DS; Lai TY; Lee VY; Chan CK; Liu DT; Mohamed S; Li CL
    Retina; 2009 Mar; 29(3):292-9. PubMed ID: 19287286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of retinal layer changes with vision gain in diabetic macular edema during conbercept treatment.
    Xu Y; Qu Y; Suo Y; Gao J; Chen X; Liu K; Xu X
    BMC Ophthalmol; 2019 May; 19(1):123. PubMed ID: 31151389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedema.
    Do DV; Nguyen QD; Shah SM; Browning DJ; Haller JA; Chu K; Yang K; Cedarbaum JM; Vitti RL; Ingerman A; Campochiaro PA
    Br J Ophthalmol; 2009 Feb; 93(2):144-9. PubMed ID: 19174400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION.
    Lotfy A; Solaiman KAM; Abdelrahman A; Samir A
    Retina; 2018 Sep; 38(9):1795-1800. PubMed ID: 28767552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates.
    Avci R; Kaderli B
    Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):28-35. PubMed ID: 16034605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary macular hole formation with presumed evulsion of foveal hard exudates in a patient with diabetic retinopathy.
    Tomita Y; Noda K; Shinoda H; Ozawa Y; Tsubota K; Ishida S
    Jpn J Ophthalmol; 2010 Jul; 54(4):366-8. PubMed ID: 20700812
    [No Abstract]   [Full Text] [Related]  

  • 32. Observation of total VEGF level in hyperglycemic mouse eyes after intravitreal injection of the novel anti-VEGF drug conbercept.
    Du L; Peng H; Wu Q; Zhu M; Luo D; Ke X; Yang P; Lei B
    Mol Vis; 2015; 21():185-93. PubMed ID: 25737631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-Dose Intravitreal Conbercept before Panretinal Photocoagulation as an Effective Adjunctive Treatment in Chinese Proliferative Diabetic Retinopathy.
    Zhang Q; Zhang T; Zhuang H; Sun Z; Qin Y
    Ophthalmologica; 2019; 242(2):59-68. PubMed ID: 30699427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
    Shimura M; Yasuda K; Shiono T
    Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes with as-needed aflibercept in diabetic macular oedema: 2-year outcomes of the ENDURANCE extension study.
    Wykoff CC; Ou WC; Khurana RN; Brown DM; Lloyd Clark W; Boyer DS;
    Br J Ophthalmol; 2018 May; 102(5):631-636. PubMed ID: 28814412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subfoveal choroidal thickness changes after intravitreal bevacizumab injection for neovascular age-related macular degeneration and diabetic macular edema.
    Ünlü C; Erdogan G; Gunay BO; Kardes E; Akcay BI; Ergin A
    Int Ophthalmol; 2017 Feb; 37(1):147-158. PubMed ID: 27154721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal triamcinolone as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant macular oedema.
    Margolis R; Singh RP; Bhatnagar P; Kaiser PK
    Acta Ophthalmol; 2008 Feb; 86(1):105-10. PubMed ID: 17608830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relation between visual acuity, fixation stability, and the size and location of foveal hard exudates after photocoagulation for diabetic maculopathy: a 1-year follow-up study.
    Møller F; Bek T
    Graefes Arch Clin Exp Ophthalmol; 2003 Jun; 241(6):458-62. PubMed ID: 12756576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti-Vascular Endothelial Growth Factor Treatment: Outcomes from the Phase 3 Program.
    Do DV; Nguyen QD; Vitti R; Berliner AJ; Gibson A; Saroj N; Soo Y; Boyer DS
    Ophthalmology; 2016 Apr; 123(4):850-7. PubMed ID: 26832658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo-controlled, clinical trial.
    Larsson J; Kifley A; Zhu M; Wang JJ; Mitchell P; Sutter FK; Gillies MC
    Acta Ophthalmol; 2009 May; 87(3):275-80. PubMed ID: 18785964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.